August, 2010
No. 95 (8)

Editorials

Articles

Regulation of divalent metal transporter 1 (DMT1) non-IRE isoform by the microRNA Let-7d in erythroid cells

Immacolata Andolfo, Luigia De Falco, Roberta Asci, Roberta Russo, Simona Colucci, Marisa Gorrese, Massimo Zollo, Achille Iolascon

https://doi.org/10.3324/haematol.2009.020685

Mechanism of human Hb switching: a possible role of the kit receptor/miR 221-222 complex

Marco Gabbianelli, Ugo Testa, Ornella Morsilli, Elvira Pelosi, Ernestina Saulle, Eleonora Petrucci, Germana Castelli, Serena Giovinazzi, Gualtiero Mariani, Micol E. Fiori, Giuseppina Bonanno, Adriana Massa, Carlo M. Croce, Laura Fontana, Cesare Peschle

https://doi.org/10.3324/haematol.2009.018259

Investigating the key membrane protein changes during in vitro erythropoiesis of protein 4.2 (−) cells (mutations Chartres 1 and 2)

Emile van den Akker, Timothy J. Satchwell, Stephanie Pellegrin, Joanna F. Flatt, Michel Maigre, Geoff Daniels, Jean Delaunay, Lesley J. Bruce, Ashley M. Toye

https://doi.org/10.3324/haematol.2009.021063

Extracranial internal carotid arterial disease in children with sickle cell anemia

Colin R. Deane, David Goss, Jack Bartram, Keith R.E. Pohl, Susan E. Height, Naomi Sibtain, Jozef Jarosz, Swee Lay Thein, David C. Rees

https://doi.org/10.3324/haematol.2010.022624

Mutations in the ribosomal protein genes in Japanese patients with Diamond-Blackfan anemia

Yuki Konno, Tsutomu Toki, Satoru Tandai, Gang Xu, RuNan Wang, Kiminori Terui, Shouichi Ohga, Toshiro Hara, Asahito Hama, Seiji Kojima, Daiichiro Hasegawa, Yoshiyuki Kosaka, Ryu Yanagisawa, Kenichi Koike, Rie Kanai, Tsuyoshi Imai, Teruaki Hongo, Myoung-Ja Park, Kanji Sugita, Etsuro Ito

https://doi.org/10.3324/haematol.2009.020826

Frequency and natural history of inherited bone marrow failure syndromes: the Israeli Inherited Bone Marrow Failure Registry

Hannah Tamary, Daniella Nishri, Joanne Yacobovich, Rama Zilber, Orly Dgany, Tanya Krasnov, Shraga Aviner, Polina Stepensky, Shoshana Ravel-Vilk, Menachem Bitan, Chaim Kaplinsky, Ayelet Ben Barak, Ronit Elhasid, Joseph Kapelusnik, Ariel Koren, Carina Levin, Dina Attias, Ruth Laor, Isaac Yaniv, Philip S. Rosenberg, Blanche P. Alter

https://doi.org/10.3324/haematol.2009.018119

Deferasirox is a powerful NF-κB inhibitor in myelodysplastic cells and in leukemia cell lines acting independently from cell iron deprivation by chelation and reactive oxygen species scavenging

Emanuela Messa, Sonia Carturan, Chiara Maffè, Marisa Pautasso, Enrico Bracco, Antonella Roetto, Francesca Messa, Francesca Arruga, Ilaria Defilippi, Valentina Rosso, Chiara Zanone, Antonia Rotolo, Elisabetta Greco, Rosa M. Pellegrino, Daniele Alberti, Giuseppe Saglio, Daniela Cilloni

https://doi.org/10.3324/haematol.2009.016824

Early intervention during imatinib therapy in patients with newly diagnosed chronic-phase chronic myeloid leukemia: a study of the Spanish PETHEMA group

Francisco Cervantes, Pilar López-Garrido, María-Isabel Montero, Fermín Jonte, Jesús Martínez, Juan-Carlos Hernández-Boluda, María Calbacho, Anna Sureda, Gloria Pérez-Rus, José B. Nieto, Cristina Pérez-López, José Román-Gómez, Marcos González, Arturo Pereira, Dolors Colomer

https://doi.org/10.3324/haematol.2009.021154

Micro-RNA response to imatinib mesylate in patients with chronic myeloid leukemia

Stéphane Flamant, William Ritchie, Joëlle Guilhot, Jeff Holst, Marie-Laure Bonnet, Jean-Claude Chomel, François Guilhot, Ali G. Turhan, John E.J. Rasko

https://doi.org/10.3324/haematol.2009.020636

Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype

Santiago Montes-Moreno, Ana-Rosa Gonzalez-Medina, Socorro-María Rodriguez-Pinilla, Lorena Maestre, Lydia Sanchez-Verde, Giovanna Roncador, Manuela Mollejo, Juan F. García, Javier Menarguez, Carlos Montalbán, M. Carmen Ruiz-Marcellan, Eulogio Conde, Miguel A. Piris

https://doi.org/10.3324/haematol.2009.016113

Evaluation of the (R)VAD+C regimen for the treatment of newly diagnosed mantle cell lymphoma. Combined results of two prospective phase II trials from the French GOELAMS group

Rémy Gressin, Sylvie Caulet-Maugendre, Eric Deconinck, Olivier Tournilhac, Emmanuel Gyan, Marie Pierre Moles, Abderrazak El Yamani, Jerome Cornillon, Jean François Rossi, Steven Le Gouill, Gérard Lepeu, Ghandi Damaj, Philippe Solal Celigny, Hervé Maisonneuve, Bernadette Corront, Jean Pierre Vilque, Philippe Casassus, Thierry Lamy, Marc Colonna, Philippe Colombat

https://doi.org/10.3324/haematol.2009.011759

Antithrombin Murcia (K241E) causing antithrombin deficiency: a possible role for altered glycosylation

Irene Martínez-Martínez, Adriana Ordóñez, José Navarro-Fernández, Ángel Pérez-Lara, Ricardo Gutiérrez-Gallego, Rafael Giraldo, Constantino Martínez, Esther Llop, Vicente Vicente, Javier Corral

https://doi.org/10.3324/haematol.2009.015487

Reduced survival of type 2B von Willebrand factor, irrespective of large multimer representation or thrombocytopenia

Alessandra Casonato, Lisa Gallinaro, Maria Grazia Cattini, Elena Pontara, Roberto Padrini, Antonella Bertomoro, Viviana Daidone, Antonio Pagnan

https://doi.org/10.3324/haematol.2009.019927

The nature of peptides presented by an HLA class I low expression allele

Jan Hinrichs, Daniel Föll, Christina Bade-Döding, Trevor Huyton, Rainer Blasczyk, Britta Eiz-Vesper

https://doi.org/10.3324/haematol.2009.016089

Identification of a panel of ten cell surface protein antigens associated with immunotargeting of leukemias and lymphomas by peripheral blood γδ T cells

Anita Q. Gomes, Daniel V. Correia, Ana R. Grosso, Telma Lança, Cristina Ferreira, João F. Lacerda, João T. Barata, Maria Gomes da Silva, Bruno Silva-Santos

https://doi.org/10.3324/haematol.2009.020602

Letters to the Editor


Myeloproliferative Neoplasms

Hydroxyurea does not appreciably reduce JAK2 V617F allele burden in patients with polycythemia vera or essential thrombocythemia

Elisabetta Antonioli, Alessandra Carobbio, Lisa Pieri, Alessandro Pancrazzi, Paola Guglielmelli, Federica Delaini, Vanessa Ponziani, Niccolò Bartalucci, Lorenzo Tozzi, Alberto Bosi, Alessandro Rambaldi, Tiziano Barbui, Alessandro M. Vannucchi

https://doi.org/10.3324/haematol.2009.021444

Brief Reports

The response to imatinib and interferon-α is more rapid than the response to imatinib alone: a retrospective analysis of 495 Philadelphia-positive chronic myeloid leukemia patients in early chronic phase

Francesca Palandri, Fausto Castagnetti, Ilaria Iacobucci, Giovanni Martinelli, Marilina Amabile, Gabriele Gugliotta, Angela Poerio, Nicoletta Testoni, Massimo Breccia, Monica Bocchia, Monica Crugnola, Giovanna Rege-Cambrin, Bruno Martino, Ivana Pierri, Franca Radaelli, Giorgina Specchia, Fabrizio Pane, Giuseppe Saglio, Gianantonio Rosti, Michele Baccarani

https://doi.org/10.3324/haematol.2009.021246

Changes in magnetic resonance bone marrow angiogenesis on day 7 after induction chemotherapy can predict outcome of acute myeloid leukemia

Hsin-An Hou, Tiffany Ting-Fang Shih, Chieh-Yu Liu, Bang-Bin Chen, Jih-Luh Tang, Ming Yao, Shang-Yi Huang, Wen-Chien Chou, Chao-Yu Hsu, Hwei-Fang Tien

https://doi.org/10.3324/haematol.2009.019364

Long-term survival after venous thromboembolism: a retrospective selected cohort study among young women

Sylvia Reitter, Clarissa Laczkovics, Thomas Waldhoer, Michaela Mayerhofer, Christian Vutuc, Ingrid Pabinger

https://doi.org/10.3324/haematol.2009.017616

Chronic sleep deprivation markedly reduces coagulation factor VII expression

Mirko Pinotti, Cristiano Bertolucci, Elena Frigato, Alessio Branchini, Nicola Cavallari, Kenkichi Baba, Susana Contreras-Alcantara, J. Christopher Ehlen, Francesco Bernardi, Ketema N. Paul, Gianluca Tosini

https://doi.org/10.3324/haematol.2010.022475

Decision Making and Problem Solving